New liquid seizure medicine tested for youngest patients
NCT ID NCT06534502
Summary
This study aims to find the best dose and check the safety of a liquid form of the seizure medication zonisamide for children from 1 month to 17 years old who have partial-onset seizures. It will involve about 40 children and will measure the drug levels in their blood and monitor for side effects. The goal is to provide better dosing information for controlling seizures in this young age group.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPILEPSY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Le Bonheur Children's Hospital
Memphis, Tennessee, 38103, United States
Contact
-
Wake Forest University School of Medicine
Winston-Salem, North Carolina, 27101, United States
Contact
Conditions
Explore the condition pages connected to this study.